back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-10-23 20:11 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-100,000 vol |
0 | |
| Filed 2023-10-23 20:10 Tx date 2023-10-23 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-270,000 vol |
0 | |
| Filed 2022-07-20 09:43 Tx date 2022-07-20 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,800
+40,000 vol $0.095 each |
100,000 | |
| Filed 2022-06-14 11:50 Tx date 2022-06-14 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+14,000 vol $0.15 each |
60,000 | |
| Filed 2022-06-14 11:49 Tx date 2022-06-14 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,595
+11,000 vol $0.145 each |
46,000 | |
| Filed 2022-06-13 11:40 Tx date 2022-06-08 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$26,250
+150,000 vol $0.175 each |
270,000 | |
| Filed 2021-12-06 15:46 Tx date 2021-12-06 |
$MCUR
Mind Cure Health Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,100
+5,000 vol $0.22 each |
80,000 | |
| Filed 2021-08-18 12:13 Tx date 2021-08-18 |
$MCUR
Mind Cure Health Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,894
+35,000 vol $0.3684 each |
75,000 | |
| Filed 2021-08-04 17:57 Tx date 2021-07-28 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+120,000 vol |
120,000 | |
| Filed 2021-05-17 10:20 Tx date 2021-05-17 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,800
+10,000 vol $0.58 each |
35,000 | |
| Filed 2021-05-17 09:40 Tx date 2021-05-17 |
$MCUR
Mind Cure Health Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,700
+20,000 vol $0.335 each |
40,000 | |
| Filed 2021-05-11 11:55 Tx date 2021-05-11 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,500
+25,000 vol $0.70 each |
25,000 | |
| Filed 2021-04-30 15:33 Tx date 2021-04-29 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-30 15:32 Tx date 2021-04-29 |
$DMT
Small Pharma Inc. (formerly, Unilock Capital Corp.) |
Wolfe, Michael Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-28 11:38 Tx date 2021-04-19 |
$MCUR
Mind Cure Health Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$210,000
+350,000 vol $0.60 each |
350,000 | |
| Filed 2021-04-28 11:35 Tx date 2021-04-19 |
$MCUR
Mind Cure Health Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-27 22:11 Tx date 2021-04-19 |
$MCUR
Mind Cure Health Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2021-01-04 16:00 Tx date 2020-12-31 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$7,124
+8,209 vol $0.87 each |
29,080 | |
| Filed 2020-10-06 06:59 Tx date 2020-09-30 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$14,250
+14,397 vol $0.99 each |
20,871 | |
| Filed 2020-07-04 18:36 Tx date 2020-06-30 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$14,998
+16,199 vol $0.93 each |
26,199 | |
| Filed 2019-04-15 17:26 Tx date 2019-04-11 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$14,999
+3,856 vol $3.89 each |
6,474 | |
| Filed 2018-06-07 Tx date 2017-07-31 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-07 Tx date 2018-06-06 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,309 vol |
2,618 | |
| Filed 2018-06-07 Tx date 2018-06-06 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,309 vol |
1,309 | |
| Filed 2017-11-30 Tx date 2017-11-28 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$23,500
+10,000 vol $2.35 each |
10,000 | |
| Filed 2017-08-10 Tx date 2017-08-08 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Stock Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2017-07-31 Tx date 2017-07-31 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-31 Tx date 2017-07-31 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-31 Tx date 2017-07-31 |
$BYL
Baylin Technologies Inc. |
Wolfe, Michael Andrew
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|